- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Non-Small Cell Lung Cancer
Total 8304 results
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
University of California, San FranciscoAstraZenecaActive, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Cancer | Stage IB Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Cancer | Stage IIB Non-Small Cell Lung CancerUnited States
-
Hubei Cancer HospitalRecruitingNon Small Cell Lung Cancer | Radiotherapy | Immunotherapy | Locally AdvancedChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
Beijing Biostar Pharmaceuticals Co., Ltd.RecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingRelapsed or Advanced Non-small Cell Lung Cancer
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, Germany, Italy, Poland, Belgium, Mexico, Turkey, Spain, France, United States, Canada, Taiwan, Brazil, Austria, Hong Kong, India, Japan, Netherlands, Denmark
-
Tianjin Medical University Cancer Institute and...Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingResectable Locally Advanced Non-small Cell Lung CancerChina
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerKorea, Republic of, Italy, Poland, Malaysia, Taiwan, Thailand, United States, France, Netherlands, Philippines, Canada, Singapore, Spain, Turkey, Australia, Belgium, Israel
-
Hangzhou ACEA Pharmaceutical Research Co., Ltd.Guangdong Provincial People's HospitalNot yet recruitingAdvanced Non-small Cell Lung CancerChina
-
AstraZenecaParexelActive, not recruitingAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, Romania, Canada, Korea, Republic of, Brazil, Hungary, Japan, China, Taiwan, Hong Kong, United Kingdom, Germany, Poland, Australia, Netherlands, Serbia, India, Argentina, Ireland
-
Institut Claudius RegaudMerck KGaA, Darmstadt, GermanyCompletedLocally Advanced Non Small Cell Lung Cancer (NSCLC)France
-
AstraZenecaTerminated
-
Taiho Oncology, Inc.CompletedAdvanced or Metastatic Non-small Cell Lung CancerUnited States, France, Poland, Spain, Italy, Japan
-
Swiss Group for Clinical Cancer ResearchCompletedLung Cancer | KRAS Gene Mutation | Advanced Non-small Cell Lung CancerSwitzerland
-
OSI PharmaceuticalsCompletedAdvanced Non Small Cell Lung Cancer | Failed Prior ChemotherapyUnited States
-
Case Comprehensive Cancer CenterTerminatedAdvanced (Stage IV) Non-small Cell Lung Cancer (NSCLC)United States
-
Ass. Prof. Jan NymanTerminatedNon Small Cell Lung Cancer | Locally Advanced DiseaseSweden
-
Hummingbird BioscienceMerck KGaA, Darmstadt, GermanyRecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAustralia, Singapore
-
J Ints BioRecruitingEGFR Mutant Advanced Non-small Cell Lung CancerKorea, Republic of, United States, Thailand
-
Qianfoshan HospitalRecruitingMetastatic NSCLC | Locally Advanced Non-Small Cell Lung CancerChina
-
Institut BergoniéAstraZenecaRecruitingNon Small Cell Lung Cancer | Advanced Solid TumorFrance
-
Shanghai Junshi Bioscience Co., Ltd.CompletedTreatment-naive Advanced Non-small Cell Lung CancerChina
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
Yuankai ShiUnknownAdvanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Non-Small Cell Lung Cancer | Other Solid Tumors
-
Zhejiang Genfleet Therapeutics Co., Ltd.RecruitingAdvance Non-small Cell Lung CancerSpain, Italy, Greece
-
AIO-Studien-gGmbHBristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaboratorsRecruitingSmall-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage IIGermany
-
Betta Pharmaceuticals Co., Ltd.Active, not recruitingAdvanced or Metastatic Non-small Cell LungChina
-
AbbVieActive, not recruitingAdvanced Solid Tumors Cancer | Non Small Cell Lung Cancer (NSCLC)United States, Australia, France, Israel, Japan, Korea, Republic of, Spain, Taiwan
-
RaND BiosciencesNot yet recruitingAdvanced Biliary Tract Cancer | Advanced Non-small-cell Lung Cancer
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedAdvanced Stage Non-small Cell Lung CancerUnited States
-
TheraOpAstraZenecaActive, not recruitingStage III Non-small Cell Lung Cancer | Locally Advanced | UnresectableSwitzerland
-
Istituto Oncologico Veneto IRCCSMinistry of Health, ItalyCompletedAdvanced Non Small Cell Lung CancerItaly
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Metastatic Lung Cancer | Advanced Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | Squamous Cell Lung CancerUnited States
-
Jun Zhang, MD, PhDGenentech, Inc.; ExelixisNot yet recruitingLung Cancer | NSCLC Stage IV | Advanced NSCLC | Metastatic NSCLC - Non-Small Cell Lung CancerUnited States
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Non-Small Cell Lung Cancer | EGFR Exon20 Insertion Mutations
-
Janssen Research & Development, LLCActive, not recruitingAdvanced or Metastatic Non-small Cell Lung CancerItaly, United States, Germany, Japan, China, Korea, Republic of, Israel, Portugal, Taiwan, Thailand, Malaysia, United Kingdom, Australia, Turkey, Poland, Spain, Brazil, Canada, Argentina, France
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
Radboud University Medical CenterCompletedNSCLC | Locally Advanced Non-Small Cell Lung CancerNetherlands
-
Stanford UniversityAstraZenecaRecruitingNon-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIUnited States
-
Soroka University Medical CenterUnknownLocally Advanced Inoperable Non-small-lung CancerIsrael
-
Fondazione Ricerca TraslazionaleUnknownNon Small Cell Lung Cancer | Metastatic Cancer | Advanced CancerItaly
-
Criterium, Inc.EMD Serono Research & Development Institute, Inc.TerminatedAdvanced Non-Small Cell Lung Cancer With MET MutationsUnited States
-
Fujian Cancer HospitalEnrolling by invitation
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
Chao HuangUniversity of Kansas Medical CenterActive, not recruitingAdvanced Solid Tumor | Non-small Cell Lung Cancer (NSCLC)United States
-
Jeffrey ClarkeNovartis Pharmaceuticals; NantCell, Inc.CompletedAdvanced Solid Tumors, Non-small Cell Lung CancerUnited States
-
PfizerCompletedNon Small Cell Lung Cancer | Advanced Solid TumorsUnited States